08189 TEDA BIOMEDICAL
- 0.360
- 0.0000.00%
TEDA BIOMEDICAL News
Citic sec: Global demand remains strong, and the leading potash fertilizer producer's production cut may raise prices.
Citic sec predicts that the supply and demand for global potassium fertilizer will be tight in 2025, and potassium fertilizer prices are expected to rebound from the bottom.
Sinolink: Potash fertilizer supply is expected to be jointly controlled, and resource prices are expected to provide support.
Only 11 companies have a potassium chloride production capacity exceeding 2 million tons, mainly concentrated in Canada nutrien, Belarus Belaruskali, Russia Uralkali, and the usa Mosaic, with a combined production capacity accounting for 67.26% of the industry, high industry concentration.
Teda Biomedical (08189) has appointed Liu Jinyu as the Chairman of the Supervisory Board.
teda biomedical (08189) announced that Ms. Yang Chunyan has resigned from the company and has submitted her resignation to the board of supervisors, resigning as a supervisor and...
CICC: Global potassium fertilizer production capacity is limited, bullish on the industry's outlook.
In 2024, the contract price for imported potash fertilizer is CFR $273 per ton, and the corresponding domestic market price including taxes is estimated to be around 2,300 yuan per ton. Considering the support role of the contract price of potash fertilizer and the subsequent gradual entry into the peak season for fertilizer use, I am bullish on the maintenance of a prosperous domestic potash fertilizer price.
TEDA BIOMEDICAL: Interim Report 2024
TEDA BIOMEDICAL: ANNOUNCEMENT ON HALF-YEARLY RESULTS FOR 2024
Shanghai will develop new technologies such as embodied intelligence and generative AI. By 2027, it will preliminarily establish a highland for retirement technology innovation and industrial development.
The Shanghai Municipal People's Government Office issued a notice on the 'Shanghai Retirement Technology Innovation and Development Action Plan'.
Citic sec's outlook for the second half of 2024 in the potash fertilizer industry: continued demand recovery and reduced supply disturbance.
The range of the global potash fertilizer price bottom is expected to be clearer in 2024.
TEDA BIOMEDICAL: Annual Report 2023
Teda Biotech (08189) proposes to appoint Tu Xiangzhen as an independent non-executive director
Teda Biotech (08189) announced that Mr. Li Xudong has resigned as an independent non-executive director and will no longer serve on the company's audit committee...
TEDA BIOMEDICAL: ANNOUNCEMENT ON ANNUAL RESULTS FOR 2023
Teda Biotech (08189.HK) plans to sell 82.76% of Shanghai Weidi's shares for 10.593 million yuan
Gelonghui, March 27, 丨 Teda Biotech (08189.HK) announced that on January 31, 2024, the company signed an equity transfer agreement. Based on this, the company agreed to sell 82.76% of Shanghai Weidi's shares to the buyer at a cost of RMB 10.593 million. After completion, the company will still hold 17.24% of Shanghai Weidi's shares. In view of Shanghai Weidi's performance over the past two years and uncertainty about future prospects, the board of directors believes that the sale is a good opportunity for the company to monetize its investment in Shanghai. Additionally, considering the proceeds from the sale, the company is able to reallocate its resources to its existing
Teda Biotech (08189): Qin Wenhua Resigns as Co-CEO
Zhitong Finance App News, Teda Biotech (08189) issued an announcement. Qin Wenhua has resigned as Co-CEO due to busy affairs and other personal reasons, effective March 26, 2024.
Huatai Securities: The silver economy may spawn a series of investment opportunities from the capital side, demand side, and supply side
As China's aging deepens, the introduction of the first banking economic policy may spawn a series of investment opportunities from the demand side, supply side, and capital side.
Demand for spring farming led to a rebound in the urea market and repair profit margins, but far from the previous year|Industry News
① Spring cultivation and preparation for cultivation have been carried out one after another. Many urea manufacturers, such as Hualu Hengsheng, Sichuan Meifeng, Liuguo Chemical, and Lutianhua, raised the ex-factory price of urea products by about 50 yuan to 60 yuan/ton, and the price increase of urea prices was nearly 8% in the past month; ② Under high supply, urea prices were only 80% of the same period last year, and the profit margin was less than the same period last year.
Ministry of Civil Affairs: Increase the supply of old-age services and cultivate new forms of old-age services
Li Yongxin, head of the Department of Elderly Care Services of the Ministry of Civil Affairs, said at a press conference that in the next step, the Ministry of Civil Affairs will increase the supply of old-age services. Develop meal aid services for the elderly, guide all regions to implement action plans to actively develop meal aid services for the elderly, innovate organizational forms, service models and operating mechanisms for the elderly, and continuously expand the scope and improve quality and efficiency on a sustainable basis.
TEDA BIOMEDICAL: Third Quarterly Report 2023
Teda Biotech (08189) released the first three quarter results, losses attributable to shareholders of 17.2942 million yuan narrowed 20.03% year-on-year
Teda Biotech (08189) announced its results for the third quarter of 2023. The group achieved revenue from continuing operations during the period...
TEDA BIOMEDICAL: ANNOUNCEMENT ON THIRD QUARTERLY RESULTS FOR 2023
TEDA BIOMEDICAL: Interim Report 2023
Analysis
Price Target
No Data
No Data